down arrow

Apeloa Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000Q45
CNY
16.11
-0.15 (-0.92%)

Dec 05

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Apeloa Pharmaceutical Co., Ltd.
Why is Apeloa Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 7.61% and Operating profit at 5.73% over the last 5 years
2
The company has declared negative results for the last 2 consecutive quarters
  • OPERATING CASH FLOW(Y) Lowest at CNY 665.22 MM
  • ROCE(HY) Lowest at 14.82%
  • INTEREST(Q) At CNY 5.67 MM has Grown at 21.2%
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -9.24% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Apeloa Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Apeloa Pharmaceutical Co., Ltd.
-0.62%
0.19
28.80%
China Shanghai Composite
15.19%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.61%
EBIT Growth (5y)
5.73%
EBIT to Interest (avg)
41.94
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
1.20
Tax Ratio
13.86%
Dividend Payout Ratio
40.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.98%
ROE (avg)
17.14%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.74
EV to EBIT
20.09
EV to EBITDA
11.86
EV to Capital Employed
2.85
EV to Sales
1.65
PEG Ratio
NA
Dividend Yield
4.48%
ROCE (Latest)
14.18%
ROE (Latest)
14.23%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
INTEREST COVERAGE RATIO(Q)

Highest at 8,907.94

DIVIDEND PAYOUT RATIO(Y)

Highest at 128.26%

RAW MATERIAL COST(Y)

Fallen by -7.99% (YoY

DIVIDEND PER SHARE(HY)

Highest at CNY 4.11

OPERATING PROFIT(Q)

Highest at CNY 505.2 MM

OPERATING PROFIT MARGIN(Q)

Highest at 18.72 %

-30What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 665.22 MM

ROCE(HY)

Lowest at 14.82%

INTEREST(Q)

At CNY 5.67 MM has Grown at 21.2%

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.11%

NET SALES(Q)

Lowest at CNY 2,698.32 MM

Here's what is working for Apeloa Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Highest at 8,907.94
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Interest Coverage Ratio
Highest at 8,907.94
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Operating Profit
Highest at CNY 505.2 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit
Highest at CNY 505.2 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin
Highest at 18.72 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Operating Profit Margin
Highest at 18.72 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Dividend per share
Highest at CNY 4.11
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend per share
Highest at CNY 4.11
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio
Highest at 128.26%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Dividend Payout Ratio
Highest at 128.26%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -7.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Raw Material Cost
Fallen by -7.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Apeloa Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at CNY 665.22 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Cash Flow
Lowest at CNY 665.22 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest
At CNY 5.67 MM has Grown at 21.2%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest
At CNY 5.67 MM has Grown at 21.2%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Sales
Lowest at CNY 2,698.32 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Net Sales
Lowest at CNY 2,698.32 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (CNY MM)

Debtors Turnover Ratio
Lowest at 4.11%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Debtors Turnover Ratio
Lowest at 4.11%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."